Q4 2019 Brainstorm Cell Therapeutics Inc Earnings Call Transcript
Greetings and welcome to the BrainStorm Cell Therapeutics fourth quarter 2019 earnings conference call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. (Operator Instructions) As a reminder, this conference is being recorded. It is my pleasure to introduce your host, Sean Leous with ICR. Please go ahead.
Thank you for joining the BrainStorm Cell Therapeutics fourth quarter and full year 2019 financial results conference.
Before we begin the prepared remarks, we would like to remind listeners that this conference contains numerous statements, descriptions, forecasts, and projections regarding BrainStorm Cell Therapeutics, Inc., Nasdaq: BCLI, and it's potential future business operations and performance statements regarding the market potential for treatment of neurodegenerative disorders such as ALS and MS, sufficiency of our existing capital resources for continuing operations in 2020 and beyond, the safety and clinical effectiveness of our NurOwn
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |